Corrigendum to "A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination" [Virology 566 (2022) 56-59]

Affiliations

• ¹ Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, China.
• ² Jiangsu Rec-Biotech Co., Ltd., Taizhou, China.
• ³ Jiangsu Rec-Biotech Co., Ltd., Taizhou, China. Electronic address: liuy@recbio.com.
• ⁴ Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, China. Electronic address: xyfan008@fudan.edu.cn.